3,5-diamino-6-chloro-N-(N-(4-(4-(2,3-dihydroxypropoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide

Catalog No. :
ACAPXC035
CAS No. :
587879-32-1
Molecular Formula :
C19H26ClN7O4
Molecular Weight :
451.92

IUPAC Name:3,5-diamino-6-chloro-N-(N-(4-(4-(2,3-dihydroxypropoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide

3,5-diamino-6-chloro-N-(N-(4-(4-(2,3-dihydroxypropoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,5-diamino-6-chloro-N-(N-(4-(4-(2,3-dihydroxypropoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
IUPAC Name3,5-diamino-6-chloro-N-(N-(4-(4-(2,3-dihydroxypropoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
Molecular FormulaC19H26ClN7O4
Molecular Weight451.92
SMILESN=C(NCCCCC1=CC=C(OCC(O)CO)C=C1)NC(=O)C1=NC(Cl)=C(N)N=C1N
InChI KeyNTRKMGDUWYBLMS-UHFFFAOYSA-N
Synonym552-02 Free base | UNII-2WWN8F640E | 2WWN8F640E | 587879-32-1 | CHEMBL212432 | 2-Pyrazinecarboxamide, 3,5-diamino-6-chloro-N-(((4-(4-(2,3-dihydroxypropoxy)phenyl)butyl)amino)iminomethyl)- | N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N'-(4-(4-(2,3-dihydroxypropoxy)ph
CAS No.587879-32-1
PubChem CID10310524

Synthetic Route by SureRoute

1. ACAPXC035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAPXC035 route product structure diagram
    ACAPXC035587879-32-1
Inquiry

2. ACAPXC035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAPXC035 route product structure diagram
    ACAPXC035587879-32-1
Inquiry

Comments (0)